Uzm. Dr. Kadriye Başkurt

Doctor and researcher Ankara Etlik Şehir Hastanesi Ankara
Breast NeoplasmsNeoplasmsPeripheral Nervous System DiseasesColorectal NeoplasmsLung Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Neoplasms 2 publications
  • Peripheral Nervous System Diseases 2 publications
  • Colorectal Neoplasms 2 publications
  • Lung Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • Department name at the sourceOnkolojisaglik.gov.trFrom source
  • InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 3 publications · Model version —From source
  • Publications61 publicationsORCID, OpenAlex, Europe PMCFrom source
  • ORCID0000-0002-6091-730XORCIDFrom source
  • Last synchronised5 November 2026 07:23https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#kadriye-baskurtsaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

61 publications

  1. Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

    The Breast, 2026

    DOI 10.1016/j.breast.2026.104936 PMID 42777557 Open-access full textSource: ORCID

  2. Serum Vitamin D as a Predictor of Immunotherapy Response in Advanced Non-small Cell Lung Cancer

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-4-7 Open-access full textSource: OpenAlex

  3. Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation

    The oncologist, 2026

    DOI 10.1093/oncolo/oyag396 PMID 42836684 Open-access full textSource: Europe PMC

  4. Integrated assessment of cachexia, body composition, and patient-reported outcomes in unplanned hospitalizations of patients with metastatic cancer (PRO-HAND study).

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.12075 Source: OpenAlex

  5. Clinicopathologic Characteristics, Treatment Patterns, and Survival Outcomes in Malignant Mesothelioma: A Population-based SEER Study, 2004-2023

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-8-2 Open-access full textSource: OpenAlex

  6. Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)

    Clinical Colorectal Cancer, 2026

    DOI 10.1016/j.clcc.2025.10.002 PMID 41198426 1 citation (Europe PMC) Source: ORCID

  7. Prognostic value of the lymphocyte‑albumin‑neutrophil ratio in de novo metastatic colorectal cancer: A continuous‑variable analysis

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15922 Open-access full textSource: OpenAlex

  8. Structural Acceleration in Sepsis-Associated Cancer Mortality in an Aging Population: A Nationwide Study in the United States, 1999–2020

    SSRN Electronic Journal, 2026

    DOI 10.2139/ssrn.6201853 Open-access full textSource: OpenAlex

  9. Temporal trends in venous thromboembolism–related mortality among gastric cancer deaths in the United States, 1999–2020.

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1893840 Open-access full textSource: OpenAlex

  10. Temporal Trends and Demographic Disparities in Prostate Cancer Mortality in the United States, 1999-2020: A CDC WONDER Analysis

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-8-1 Open-access full textSource: OpenAlex

View all 61 publications